Geron And GE Enter Joint Development

Geron Corp. (Nasdaq: GERN) and GE Healthcare, a unit of General Electric (NYSE: GE) agreed to conduct joint research to develop embryonic stem cell products. Shares of Geron climbed $1.02 to $7.71 wile GE stock slipped 15 cents to $11.61.

About this Entry

This page contains a single entry by published on June 30, 2009 10:58 AM.

AIG To Sell Russian Business was the previous entry in this blog.

AIG Sells Taiwan Credit Card Unit is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12